CEPI, THSTI and Panacea to develop vaccines for betacoronaviruses
The CEPI is set to collaborate with the THSTI and Panacea Biotec ro develop vaccines for SARS-Cov-2 variants and other Betacoronaviruses.
Source: pharmaceutical-technology.com
Stay updated with breaking news from Software Solutions For. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The CEPI is set to collaborate with the THSTI and Panacea Biotec ro develop vaccines for SARS-Cov-2 variants and other Betacoronaviruses.
Ventus Therapeutics has raised $140m in a Series C funding round to accelerate its drug discovery platform, ReSOLVE.
Sarepta entered a research partnership and option agreement with GenEdit to develop gene-editing therapies for neuromuscular diseases.